-
PI3K and AKT Inhibitor Toxicity Advice From a Breast Cancer Expert
04 Aug 2025 16:13 GMT
… medical oncology, as well as director of the Women's Cancers … capivasertib and all the drugs that cause hyperglycemia, because … steroid mouthwash for everolimus [Afinitor] to reduce the mouth … important to do prevention than treatment [with rashes].
What …
-
Key Advances Across Kidney Cancer Research and Management at KCRS 2025
28 Jul 2025 15:39 GMT
… personalized neoantigen cancer vaccine as a treatment for those … hypothesis-testing clinical trials in RCC.4 Jonasch … the Division of Cancer Medicine at The University … trial consortium to accelerate kidney cancer research. Presented at the 2025 Kidney Cancer …
-
Proactive Rash Management Vital for PI3K, AKT Inhibition in Breast Cancer
28 Jul 2025 19:12 GMT
For patients with breast cancer receiving treatment with PI3K or AKT inhibitors … the steroid mouthwash for everolimus [Afinitor] to reduce the mouth sores … with some of the other drugs, although we saw it as … that they can cut the pill in half. Just tell people …
-
Celcuity’s triple cancer drug combo tops AstraZeneca’s in cutting progression in study
28 Jul 2025 12:09 GMT
… type of advanced breast cancer, sending the biotech firm’s shares surging … drugs called PAM inhibitors, which include Novartis’ Afinitor and AstraZeneca’s Truqap.
The treatment … and data from a separate trial in patients whose tumors had …
-
Celcuity Announces Clinically Meaningful Improvement in Both Progression-Free Survival (“PFS”) Primary Endpoints from PIK3CA Wild-Type Cohort of Phase 3 VIKTORIA-1 Trial
28 Jul 2025 11:00 GMT
… drug development for HR+/HER2- advanced breast cancer
Treatment … CELC), a clinical-stage biotechnology company pursuing development of … of Medicine and co-principal investigator for the trial said: … States Package Insert, US FDA, AFINITOR
Lloyd M R, …
-
Ongoing Research Aims to Alter Management of HR+ Breast Cancer After Frontline CDK4/6 Inhibition
25 Jul 2025 04:20 GMT
… an assistant professor of medicine at the University of … inhibitor treatment landscape in hormone receptor–positive breast cancer; the … 6 inhibitor, or everolimus [Afinitor] is still an option with … There are also ongoing trials looking at using oral …
-
drugs that target the HER2 protein
10 Jul 2025 20:31 GMT
… .
mTOR inhibitor
Everolimus (Afinitor) blocks mTOR, a … sugar levels, signs of kidney, liver, or pancreatic … cancer has grown during or after treatment with hormone therapy. Your doctor … starting treatment with this drug.
This drug is taken as pills, …
-
Targeted Therapies Broaden Treatment Options for CDK4/6 Inhibitor–Resistant, HR+ Breast Cancer
10 Jul 2025 14:10 GMT
… HER2-negative metastatic breast cancer; the critical role … treatment decisions; and ongoing challenges regarding treatment sequencing, drug … of Hematology and Medical Oncology at Emory … fulvestrant plus everolimus [Afinitor]. Everolimus benefits patients …
-
Breaking Down the Treatment Options for HER2-Negative Breast Cancer
01 Jul 2025 14:46 GMT
… learn more about treatments for HER2-negative breast cancer.
Doctors may recommend … HER2-negative breast cancer. The drugs for this treatment can prevent estrogen … Afinitor)
the PI3K inhibitor alpelisib (Piqray)
the AKT inhibitor capivasertib (Truqap)
Cancers …
-
Korea lags behind global standards in kidney cancer treatment, expert warns
19 Jun 2025 09:18 GMT
… Medical Center and Paik Jin-young, head of the Korea Kidney Cancer … cell renal cancer,” Park noted. “Afinitor is …
Park emphasized that kidney cancer drug treatment has improved significantly, … treatment options,” Paik said. “If a doctor believes a certain drug …